| Product NDC: | 0004-0820 | 
| Proprietary Name: | Tamiflu | 
| Non Proprietary Name: | Oseltamivir Phosphate | 
| Active Ingredient(s): | 6 mg/mL & nbsp; Oseltamivir Phosphate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | POWDER, FOR SUSPENSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0004-0820 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021246 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20110711 | 
| Package NDC: | 0004-0820-09 | 
| Package Description: | 1 BOTTLE, GLASS in 1 CARTON (0004-0820-09) > 60 mL in 1 BOTTLE, GLASS | 
| NDC Code | 0004-0820-09 | 
| Proprietary Name | Tamiflu | 
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (0004-0820-09) > 60 mL in 1 BOTTLE, GLASS | 
| Product NDC | 0004-0820 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Oseltamivir Phosphate | 
| Dosage Form Name | POWDER, FOR SUSPENSION | 
| Route Name | ORAL | 
| Start Marketing Date | 20110711 | 
| Marketing Category Name | NDA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | OSELTAMIVIR PHOSPHATE | 
| Strength Number | 6 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |